Rishabh Instruments Limited has submitted its quarterly statement on fund utilization deviation to the stock exchanges for the quarter ended December 31, 2025, in compliance with SEBI regulations. The filing reveals modifications to the company's original fund utilization plan following shareholder approval.

Fund Raising Details

The company's fund raising particulars demonstrate a structured approach to capital deployment:

Modified Fund Utilization Plan

The company has restructured its original manufacturing expansion strategy with shareholder consent. The modification involved splitting the original Nashik Manufacturing Facility I expansion into two separate facilities with revised fund allocations.

Utilization Progress

The fund utilization shows significant progress across the modified objectives. The original Nashik Manufacturing Facility I expansion, now allocated Rs. 321.80 million, has utilized Rs. 224.31 million. The newly created Nashik Manufacturing Facility II, with an allocation of Rs. 300.00 million, has deployed Rs. 204.19 million and reported a quarterly deviation of Rs. 34.45 million.

Regulatory Compliance

The statement confirms that the deviation in fund utilization was implemented pursuant to changes in contract terms and objects, which received proper shareholder approval on September 13, 2024. Both the Audit Committee and auditors have provided nil comments on the fund utilization pattern, indicating compliance with regulatory requirements.

Corporate Governance

The filing was signed by Ajinkya Joglekar, Company Secretary and Compliance Officer, and submitted to both NSE (Symbol: RISHABH) and BSE (Scrip Code: 543977) on February 5, 2026. The company maintains its commitment to transparent reporting under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Rishabh Instruments Limited has completed the allotment of 15,740 equity shares under its Employee Stock Option Plan 2022 – Scheme B to eligible employees. The Board of Directors approved this allotment through a circular resolution passed on February 4, 2026.

Share Capital Enhancement

The allotment has resulted in an increase in the company's paid-up equity share capital. The impact on the company's capital structure is detailed below:

ESOP Allotment Details

The shares were allotted under the Rishabh Instruments Limited Employee Stock Option Plan 2022 – Scheme B. Key details of the allotment include:

Regulatory Compliance

The company has fulfilled all regulatory requirements for the ESOP allotment. The newly allotted equity shares rank pari-passu with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

The company filed the required statement under Regulation 10(b) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with both BSE Limited and National Stock Exchange of India Limited on January 17, 2024, receiving filing numbers 192999 and 39556 respectively.

Share Characteristics

The allotted shares are identical in all respects to the existing shares and do not carry any lock-in restrictions. The shares will be listed on both BSE Limited (Scrip Code: 543977) and National Stock Exchange of India Limited (Symbol: RISHABH), where the company's equity shares are currently traded.

This ESOP allotment demonstrates the company's commitment to employee participation in its growth story while maintaining compliance with all applicable securities regulations.